Search results
Posts Claim Falsely That AstraZeneca Is Withdrawing Its COVID Vaccine Because of Blood Clots
The Dispatch via Yahoo News· 1 day ago(Photo Illustration by Jakub Porzycki/NurPhoto/Getty Images) Since last week, hundreds of social...
AstraZeneca's COVID-19 Prevention Therapy Cuts Risk Of Infection In Patients With Weaker Immunity,...
Benzinga via Yahoo Finance· 1 day agoThursday, AstraZeneca Plc (NASDAQ:AZN) released high-level results from the SUPERNOVA Phase 3...
‘Inhumane’: Utah mom slaps drug company with lawsuit after suffering COVID vaccine trial injuries
Fox News via Yahoo News· 5 hours agoBrianne Dressen shared with Fox News Digital why she decided to file a lawsuit against AstraZeneca...
AstraZeneca’s Phase III Covid-19 antibody trial meets primary endpoints
Clinical Trials Arena via Yahoo Finance· 10 hours agoAstraZeneca has announced that the Phase III SUPERNOVA clinical trial of its sipavibart (formerly...
Vaccine trial patient files first US lawsuit against AstraZeneca
The Telegraph via Yahoo News· 4 days agoAn American woman who took part in the US clinical trial of the AstraZeneca Covid vaccine is suing...
Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
Benzinga via Yahoo Finance· 1 day agoOn Sunday, Pfizer (NYSE: PFE) and AstraZeneca Plc (NASDAQ: AZN) were among the pharmaceutical...
New virus variants threaten a summer Covid-19 wave, but experts say the risk remains uncertain
CNN.com· 7 hours agoCovid-19 levels are about the lowest they’ve ever been in the United States, but another new crop of...
Equities Analysts Offer Predictions for AstraZeneca PLC’s Q2 2024 Earnings (NASDAQ:AZN)
ETF DAILY NEWS· 1 day agoAstraZeneca PLC (NASDAQ:AZN – Free Report) – Research analysts at Zacks Research reduced their Q2 2024 earnings per share estimates for AstraZeneca in a ...
AstraZeneca selects new heart failure target with BenevolentAI
Pharmaceutical Technology via Yahoo Finance· 1 day agoAstraZeneca has incorporated a new target for heart failure treatment into its discovery portfolio...
AstraZeneca's COVID prevention drug cuts risk of disease in vulnerable patients
Reuters via AOL· 2 days agoThe long-acting antibody therapy called sipavibart showed a "statistically significant reduction" in...